शुभ दीपावलीDiwali offer: 3 months free on yearly plans · ends 11 NovSee plans
HESTERBIONSEHester Biosciences Limited· Pharmaceuticals & BiotechnologyHighNegative
Announced Thu, 13 Nov, 2025 · 17:54 IST

Hester Biosciences CFO Divyesh Maru resigns effective Nov 13, 2025

CFO resignedManagement Changes View source PDFExplain this filing

HESTERBIO · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close
-1.6%Reaction day
₹1712.00
prior close
₹1700.00
announcement price
After-mkt
timing
Nifty Microcap 250market · in no size index; the smallest one is used-0.1%-1.5% vs market
Pharmaceuticals peers, median of 157sector+0.0%-1.6% vs sector

On the reaction day the stock moved 1.5 pts less than Nifty Microcap 250 and 1.6 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark
Stock
5m
-0.3
10m
-0.2
15m
-0.2
30m
-0.2
Sessions after the filingfrom the prior close
StockMarketvs marketSectorvs sector
Reaction day
-1.6-0.1-1.5+0.0-1.6
Next day
-3.6+0.5-4.1-0.1-3.4
2d
-1.9-0.3-1.6-0.9-1.0
3d
-0.8-0.5-0.3-1.4+0.6
4d
-0.8-0.8+0.0-1.6+0.8
5d
-2.9-2.3-0.6-2.3-0.7
1w
-4.0-2.8-1.3-2.9-1.2
15d
-3.6-4.9+1.3-3.1-0.5
1m
-6.4-4.7-1.7-4.3-2.2
2m
-13.6-7.7-5.8-5.6-7.9
3m
-8.0-7.8-0.2-10.7+2.7
UpDownMarket · Nifty Microcap 250Sector · Pharmaceuticals peers, median of 157Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Chief Financial Officer and Key Managerial Personnel Mr. Divyesh Maru resigned from Hester Biosciences, effective close of office hours on November 13, 2025, citing personal career interests. He confirmed there are no material reasons other than those stated for his exit. The company acknowledged his contributions during his tenure. No successor has been named in this filing.

Likely market impact

Routine CFO departure for personal reasons. May cause short-term uncertainty until a replacement CFO is appointed, but no governance concerns flagged.